Remission induction by Raising the dose of Remicade in RA (RRRR) study: Rationale and study protocol for a randomized controlled trial comparing for sustained clinical remission after discontinuation of infliximab in patients with rheumatoid arthrit

Remission induction by Raising the dose of Remicade in RA (RRRR) study: Rationale and study protocol for a randomized controlled trial comparing for sustained clinical remission after discontinuation of infliximab in patients with rheumatoid arthrit

Item

http://www.wikidata.org/entity/Q52562516

Q52562516

about

Remission induction by Raising the dose of Remicade in RA (RRRR) study: Rationale and study protocol for a randomized controlled trial comparing for sustained clinical remission after discontinuation of infliximab in patients with rheumatoid arthrit

Item

http://www.wikidata.org/entity/Q52562516

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Remission induction by Raising ...... tients with rheumatoid arthrit

@en

Remission induction by Raising the dose of Remicade in RA

@nl

type

Item

label

Remission induction by Raising ...... tients with rheumatoid arthrit

@en

Remission induction by Raising the dose of Remicade in RA

@nl

prefLabel

Remission induction by Raising ...... tients with rheumatoid arthrit

@en

Remission induction by Raising the dose of Remicade in RA

@nl

P1476

Remission induction by Raising ...... tients with rheumatoid arthrit

@en

P2093

Kazuyoshi Saito

http://www.w3.org/2001/XMLSchema#string

Nao Horie

http://www.w3.org/2001/XMLSchema#string

Nobuyuki Miyasaka

http://www.w3.org/2001/XMLSchema#string

Norihiro Sato

http://www.w3.org/2001/XMLSchema#string

Tsuneyo Mimori

http://www.w3.org/2001/XMLSchema#string

Yoshiya Tanaka

http://www.w3.org/2001/XMLSchema#string

P2860

Tapering biologic and conventional DMARD therapy in rheumatoid arthritis: current evidence and future directions.

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.

Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study.

Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial.

Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial.

Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of infliximab therapy in patients with rheumatoid arthritis.

Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study.

New drugs for rheumatoid arthritis.

Epidemiology and burden of illness of rheumatoid arthritis.

Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoid arthritis: 26-week results from the randomised, controlled OPTIMA s

P304

49-54

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CONCTC.2017.08.007

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tsutomu Takeuchi

Koji Oba

Takao Koike

P577

2017-08-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29696196

http://www.w3.org/2001/XMLSchema#string

P932

5898537

http://www.w3.org/2001/XMLSchema#string

Remission induction by Raising the dose of Remicade in RA (RRRR) study: Rationale and study protocol for a randomized controlled trial comparing for sustained clinical remission after discontinuation of infliximab in patients with rheumatoid arthrit

about

Remission induction by Raising the dose of Remicade in RA (RRRR) study: Rationale and study protocol for a randomized controlled trial comparing for sustained clinical remission after discontinuation of infliximab in patients with rheumatoid arthrit

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932